- Joined
- Sep 11, 2010
- Messages
- 39,201
- Points
- 113
This is old news from May 2021 but worth a revisit. So comforting to know we have a never ending supply of their mRNA vaccine to protect us. Yay!!
FILE PHOTO: A medical worker fills a syringe with a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine as Japan launches its inoculation campaign, at Tokyo Medical Center in Tokyo, Japan February 17, 2021. Behrouz Mehri/Pool via REUTERS/File Photo
SINGAPORE: German biotechnology firm BioNTech, which partnered Pfizer to develop a COVID-19 vaccine using messenger RNA (mRNA) technology, will set up its regional headquarters in Singapore, along with a manufacturing facility.
The new facility will provide "regional and global supply capacity of BioNTech's mRNA-based product candidates" and serve as "a rapid response production capability for Southeast Asia to address potential pandemic threats”, the company said on Monday (May 10).
BioNTech added that it plans to open its Singapore office and initiate construction of the manufacturing facility this year, subject to planning approval.
The facility could be operational as early as 2023 and create up to 80 jobs in Singapore.
In its media release, BioNTech said the new facility, supported by Singapore’s Economic Development Board (EDB), "will leverage cutting-edge manufacturing and digital infrastructure".
It will be equipped to "produce a range of novel mRNA vaccines and therapeutics for infectious diseases and cancer", it added.
Singapore's Trade and Industry Minister Chan Chun Sing, speaking at an online press conference after the announcement, said the new investment is “a boost” to the local biopharmaceutical ecosystem.
Noting that the new mRNA technology has “drastically reduced” the time needed for vaccines to be produced, the new facility will also strengthen the portfolio of different vaccine production technologies in Singapore, he added.
“There will be new viruses that will emerge in time to come and what we need is a strong R&D partnership to make sure that we continuously evolve our products in a timely fashion to serve our local and regional markets.”
https://www.channelnewsasia.com/bus...-mrna-singapore-regional-headquarters-1354216


FILE PHOTO: A medical worker fills a syringe with a dose of the Pfizer-BioNTech coronavirus disease (COVID-19) vaccine as Japan launches its inoculation campaign, at Tokyo Medical Center in Tokyo, Japan February 17, 2021. Behrouz Mehri/Pool via REUTERS/File Photo
SINGAPORE: German biotechnology firm BioNTech, which partnered Pfizer to develop a COVID-19 vaccine using messenger RNA (mRNA) technology, will set up its regional headquarters in Singapore, along with a manufacturing facility.
The new facility will provide "regional and global supply capacity of BioNTech's mRNA-based product candidates" and serve as "a rapid response production capability for Southeast Asia to address potential pandemic threats”, the company said on Monday (May 10).
BioNTech added that it plans to open its Singapore office and initiate construction of the manufacturing facility this year, subject to planning approval.
The facility could be operational as early as 2023 and create up to 80 jobs in Singapore.
In its media release, BioNTech said the new facility, supported by Singapore’s Economic Development Board (EDB), "will leverage cutting-edge manufacturing and digital infrastructure".
It will be equipped to "produce a range of novel mRNA vaccines and therapeutics for infectious diseases and cancer", it added.
Singapore's Trade and Industry Minister Chan Chun Sing, speaking at an online press conference after the announcement, said the new investment is “a boost” to the local biopharmaceutical ecosystem.
Noting that the new mRNA technology has “drastically reduced” the time needed for vaccines to be produced, the new facility will also strengthen the portfolio of different vaccine production technologies in Singapore, he added.
“There will be new viruses that will emerge in time to come and what we need is a strong R&D partnership to make sure that we continuously evolve our products in a timely fashion to serve our local and regional markets.”
https://www.channelnewsasia.com/bus...-mrna-singapore-regional-headquarters-1354216